Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

McNeil

This article was originally published in The Tan Sheet

Executive Summary

Sales increased 2.6% to $390 mil. in first quarter, J&J division reports April 17. "Positive results in...Children's Tylenol and Tylenol Cold as well as Children's Motrin and Motrin Cold were offset by declines in the adult analgesic category," VP-Investor Relations Helen Short says. J&J U.S. consumer health care sales rose 3.9% to $980 mil.; worldwide consumer health sales were $1.79 bil., rising 1.9%. Consolidated J&J sales of $7.79 bil. marked a 6.4% increase while U.S. sales spiked 9% to $4.58 bil. Net income jumped 14.2% to $1.5 bil. William McComb has risen to McNeil president after two years as VP-marketing. He succeeds Anthony Vernon, who moves to J&J's Centocor biotech subsidiary

You may also be interested in...



Whitehall Dimetapp Reformulations, New Products Drive U.S. Growth

Whitehall-Robins' quick reformulation and shipment of PPA-free Dimetapp products spurred a 50.3% increase in the brand's domestic sales during the first quarter. Dimetapp sales reached $23.6 mil. in the U.S., compared to $15.7 mil. in the year-ago period, Whitehall parent American Home Products said April 25.

Whitehall Dimetapp Reformulations, New Products Drive U.S. Growth

Whitehall-Robins' quick reformulation and shipment of PPA-free Dimetapp products spurred a 50.3% increase in the brand's domestic sales during the first quarter. Dimetapp sales reached $23.6 mil. in the U.S., compared to $15.7 mil. in the year-ago period, Whitehall parent American Home Products said April 25.

Whitehall Dimetapp Reformulations, New Products Drive U.S. Growth

Whitehall-Robins' quick reformulation and shipment of PPA-free Dimetapp products spurred a 50.3% increase in the brand's domestic sales during the first quarter. Dimetapp sales reached $23.6 mil. in the U.S., compared to $15.7 mil. in the year-ago period, Whitehall parent American Home Products said April 25.

Topics

UsernamePublicRestriction

Register

PS092457

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel